Found: 24
Select item for more details and to access through your institution.
Method for Teaching Life-Saving Combat First-Aid Skills With live-actor Patients Using a Wearable Training Apparatus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B‐cell lymphoma.
- Published in:
- Journal of Pathology, 2018, v. 246, n. 2, p. 141, doi. 10.1002/path.5108
- By:
- Publication type:
- Article
A Novel Scenario-Based, Mixed-Reality Platform for Training Nontechnical Skills of Battlefield First Aid: Prospective Interventional Study.
- Published in:
- JMIR Serious Games, 2022, v. 10, n. 4, p. 246, doi. 10.2196/40727
- By:
- Publication type:
- Article
Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104209
- By:
- Publication type:
- Article
Research on Thermal Load of Subway Wheels Based on Braking Conditions.
- Published in:
- Journal of Beijing University of Civil Engineering & Architecture, 2021, v. 37, n. 3, p. 77, doi. 10.19740/j.2096-9872.2021.03.10
- By:
- Publication type:
- Article
Donor-derived cell-free DNA as a diagnostic marker for kidney-allograft rejection: A systematic review and meta-analysis.
- Published in:
- Biomolecules & Biomedicine, 2024, v. 24, n. 4, p. 731, doi. 10.17305/bb.2024.10049
- By:
- Publication type:
- Article
Prognostic value of PD-L1 expression in combination with CD8<sup>+</sup> TILs density in patients with surgically resected non-small cell lung cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 1, p. 32, doi. 10.1002/cam4.1243
- By:
- Publication type:
- Article
Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.639947
- By:
- Publication type:
- Article
Exosomes transmit T790M mutation‐induced resistance in EGFR‐mutant NSCLC by activating PI3K/AKT signalling pathway.
- Published in:
- Journal of Cellular & Molecular Medicine, 2020, v. 24, n. 2, p. 1529, doi. 10.1111/jcmm.14838
- By:
- Publication type:
- Article
Inhibiting Roles of Berberine in Gut Movement of Rodents are Related to Activation of the Endogenous Opioid System.
- Published in:
- Phytotherapy Research, 2013, v. 27, n. 10, p. 1564, doi. 10.1002/ptr.4926
- By:
- Publication type:
- Article
Integrative analysis of PD‐L1 DNA status, mRNA status and protein status, and their clinicopathological correlation, in diffuse large B‐cell lymphoma.
- Published in:
- Histopathology, 2019, v. 74, n. 4, p. 618, doi. 10.1111/his.13765
- By:
- Publication type:
- Article
Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
- Published in:
- BMC Medical Genomics, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s12920-024-01866-y
- By:
- Publication type:
- Article
Clinical Effect of Intravenous Vitamin C on Viral Myocarditis in Children: A Systematic Review and Meta-Analysis.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2019, p. 1, doi. 10.1155/2019/3082437
- By:
- Publication type:
- Article
EGFR‐targeted therapy alters the tumor microenvironment in EGFR‐driven lung tumors: Implications for combination therapies.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 5, p. 1432, doi. 10.1002/ijc.32191
- By:
- Publication type:
- Article
An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0168960
- By:
- Publication type:
- Article
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Characterization of distinct types of KRAS mutation and its impact on first‑line platinum‑based chemotherapy in Chinese patients with advanced non‑small cell lung cancer.
- Published in:
- Oncology Letters, 2017, v. 14, n. 6, p. 6525, doi. 10.3892/ol.2017.7016
- By:
- Publication type:
- Article
Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes.
- Published in:
- Oncology Letters, 2017, v. 13, n. 1, p. 206, doi. 10.3892/ol.2016.5402
- By:
- Publication type:
- Article
High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 3305, doi. 10.2147/OTT.S198827
- By:
- Publication type:
- Article
Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01455
- By:
- Publication type:
- Article
Levels of lymphocyte subsets in peripheral blood prior treatment are associated with aggressive breast cancer phenotypes or subtypes.
- Published in:
- Medical Oncology, 2014, v. 31, n. 6, p. 1, doi. 10.1007/s12032-014-0981-9
- By:
- Publication type:
- Article
Correction: Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03389-w
- By:
- Publication type:
- Article